These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35244298)

  • 21. A pair of primary colorectal cancer-derived and corresponding synchronous liver metastasis-derived organoid cell lines.
    Cheng F; Li P; Xu S; Zhang C; Liang H; Ding Z
    Aging (Albany NY); 2024 Feb; 16(5):4396-4422. PubMed ID: 38407980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient-derived organoids as a model for tumor research.
    Wang J; Feng X; Li Z; Chen Y; Huang W
    Prog Mol Biol Transl Sci; 2022; 189(1):259-326. PubMed ID: 35595351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acoustic Bioprinting of Patient-Derived Organoids for Predicting Cancer Therapy Responses.
    Chen H; Wu Z; Gong Z; Xia Y; Li J; Du L; Zhang Y; Gao X; Fan Z; Hu H; Qian Q; Ding Z; Guo S
    Adv Healthc Mater; 2022 Jul; 11(13):e2102784. PubMed ID: 35358375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mimicking Tumor Cell Heterogeneity of Colorectal Cancer in a Patient-derived Organoid-Fibroblast Model.
    Atanasova VS; de Jesus Cardona C; Hejret V; Tiefenbacher A; Mair T; Tran L; Pfneissl J; Draganić K; Binder C; Kabiljo J; Clement J; Woeran K; Neudert B; Wohlhaupter S; Haase A; Domazet S; Hengstschläger M; Mitterhauser M; Müllauer L; Tichý B; Bergmann M; Schweikert G; Hartl M; Dolznig H; Egger G
    Cell Mol Gastroenterol Hepatol; 2023; 15(6):1391-1419. PubMed ID: 36868311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids.
    Cioce M; Fumagalli MR; Donzelli S; Goeman F; Canu V; Rutigliano D; Orlandi G; Sacconi A; Pulito C; Palcau AC; Fanciulli M; Morrone A; Diodoro MG; Caricato M; Crescenzi A; Verri M; Fazio VM; Zapperi S; Levrero M; Strano S; Grazi GL; La Porta C; Blandino G
    J Exp Clin Cancer Res; 2023 Jul; 42(1):170. PubMed ID: 37460938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydrogel-based colorectal cancer organoid co-culture models.
    Luo X; Fong ELS; Zhu C; Lin QXX; Xiong M; Li A; Li T; Benoukraf T; Yu H; Liu S
    Acta Biomater; 2021 Sep; 132():461-472. PubMed ID: 33388439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plocabulin Displays Strong Cytotoxic Activity in a Personalized Colon Cancer Patient-Derived 3D Organoid Assay.
    Costales-Carrera A; Fernández-Barral A; Bustamante-Madrid P; Guerra L; Cantero R; Barbáchano A; Muñoz A
    Mar Drugs; 2019 Nov; 17(11):. PubMed ID: 31752287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technologies to Assess Drug Response and Heterogeneity in Patient-Derived Cancer Organoids.
    Skala MC; Deming DA; Kratz JD
    Annu Rev Biomed Eng; 2022 Jun; 24():157-177. PubMed ID: 35259932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
    Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
    Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients.
    Chen JH; Chu XP; Zhang JT; Nie Q; Tang WF; Su J; Yan HH; Zheng HP; Chen ZX; Chen X; Song MM; Yi X; Li PS; Guan YF; Li G; Deng CX; Rosell R; Wu YL; Zhong WZ
    Thorac Cancer; 2020 Aug; 11(8):2279-2290. PubMed ID: 32633046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leveraging Patient-Derived Organoids for Personalized Liver Cancer Treatment.
    Rao J; Song C; Hao Y; Chen Z; Feng S; Xu S; Wu X; Xuan Z; Fan Y; Li W; Li J; Ren Y; Li J; Cheng F; Gu Z
    Int J Biol Sci; 2024; 20(13):5363-5374. PubMed ID: 39430248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Organoid in colorectal cancer: progress and challenges.
    Ji DB; Wu AW
    Chin Med J (Engl); 2020 Aug; 133(16):1971-1977. PubMed ID: 32826461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer.
    Cartry J; Bedja S; Boilève A; Mathieu JRR; Gontran E; Annereau M; Job B; Mouawia A; Mathias P; De Baère T; Italiano A; Besse B; Sourrouille I; Gelli M; Bani MA; Dartigues P; Hollebecque A; Smolenschi C; Ducreux M; Malka D; Jaulin F
    J Exp Clin Cancer Res; 2023 Oct; 42(1):281. PubMed ID: 37880806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organoids as a Robust Preclinical Model for Precision Medicine in Colorectal Cancer: A Systematic Review.
    Flood M; Narasimhan V; Wilson K; Lim WM; Ramsay R; Michael M; Heriot A
    Ann Surg Oncol; 2022 Jan; 29(1):47-59. PubMed ID: 34596795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microfluidic droplet encapsulation-guided organoid growth promotes parental tumor phenotype recapitulation.
    Zhang W; Jin H; Lou S; Yang H; Dai X; Ma S
    Int J Cancer; 2024 Jan; 154(1):145-154. PubMed ID: 37622267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From organoids to bedside: Advances in modeling, decoding and targeting of colorectal cancer.
    Betge J; Jackstadt R
    Int J Cancer; 2023 Apr; 152(7):1304-1313. PubMed ID: 36121667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical models as patients' avatars for precision medicine in colorectal cancer: past and future challenges.
    Durinikova E; Buzo K; Arena S
    J Exp Clin Cancer Res; 2021 Jun; 40(1):185. PubMed ID: 34090508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal cancer liver metastases organoids retain characteristics of original tumor and acquire chemotherapy resistance.
    Buzzelli JN; Ouaret D; Brown G; Allen PD; Muschel RJ
    Stem Cell Res; 2018 Mar; 27():109-120. PubMed ID: 29414601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases.
    Jian M; Ren L; He G; Lin Q; Tang W; Chen Y; Chen J; Liu T; Ji M; Wei Y; Chang W; Xu J
    J Transl Med; 2020 Jun; 18(1):234. PubMed ID: 32532289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study.
    Jensen LH; Rogatto SR; Lindebjerg J; Havelund B; Abildgaard C; do Canto LM; Vagn-Hansen C; Dam C; Rafaelsen S; Hansen TF
    J Exp Clin Cancer Res; 2023 May; 42(1):115. PubMed ID: 37143108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.